Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model [PDF]
Dean Andrew+3 more
openalex +1 more source
Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the Congo. [PDF]
Koyuncu A+18 more
europepmc +1 more source
Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia. [PDF]
Luchen CC+10 more
europepmc +1 more source
Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit [PDF]
Le Guo+6 more
openalex +1 more source
Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019-2020 targeted preventative mass campaigns. [PDF]
Briskin E+9 more
europepmc +1 more source
Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. [PDF]
Ali M+10 more
europepmc +1 more source
Knowledge and perception of a clinical trial among the participants: An experience from oral cholera vaccine study in Koshi Province, Nepal. [PDF]
Chaudhary S+16 more
europepmc +1 more source
CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe. [PDF]
Duffin RP+4 more
europepmc +1 more source
Cholera vaccines for the rich, cholera for the poor: While the global cholera vaccine stockpile runs dry, a booming market for high-income countries exemplifies the chasm between commercial interests and global health needs. [PDF]
Houston AR, Houston S.
europepmc +1 more source